SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion
Cell · 2024-02 · 187 (4) · 861-881.e32
DOI: 10.1016/j.cell.2024.01.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024-02. Verfasst von Giuseppe Leuzzi und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Cente…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Immunity, Innate, Melanoma, Tumor Escape. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA.
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.
- EpiCypher Inc., Durham, NC 27709, USA.
- Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA.
- Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Medicine, Division of Hematology and Oncology, Columbia University Irving Medical Center, N…
- Center for OncoGenomics and Innovative Therapeutics (COGIT), Center for Therapeutics Discovery, Department of Oncological Sciences and Pharmacological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount…
Förderung
- NCI NIH HHS
- NIH HHS
- NIGMS NIH HHS
- NIDCR NIH HHS
- NIH
- Associazione Italiana per la Ricerca sul Cancro
- U.S. Department of Defense
- Burroughs Wellcome Fund
Zitieren
APA
Leuzzi, G., Vasciaveo, A., Taglialatela, A., Chen, X., Firestone, T. M., Hickman, A. R., Mao, W., Thakar, T., Vaitsiankova, A., Huang, J. W., Cuella-Martin, R., Hayward, S. B., Kesner, J. S., Ghasemzadeh, A., Nambiar, T. S., Ho, P., Rialdi, A., Hebrard, M., Li, Y., …, & Ciccia, A. (2024). SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion. Cell, 187(4), 861-881.e32. https://doi.org/10.1016/j.cell.2024.01.008
Vancouver
Leuzzi G, Vasciaveo A, Taglialatela A, Chen X, Firestone TM, Hickman AR, et al. SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion. Cell. 2024;187(4):861-881.e32. doi:10.1016/j.cell.2024.01.008
BibTeX
@article{Leuzzi2024,
author = {Leuzzi, Giuseppe and Vasciaveo, Alessandro and Taglialatela, Angelo and Chen, Xiao and Firestone, Tessa M and Hickman, Allison R and Mao, Wendy and Thakar, Tanay and Vaitsiankova, Alina and Huang, Jen-Wei and Cuella-Martin, Raquel and Hayward, Samuel B and Kesner, Jordan S and Ghasemzadeh, Ali and Nambiar, Tarun S and Ho, Patricia and Rialdi, Alexander and Hebrard, Maxime and Li, Yinglu and Gao, Jinmei and Gopinath, Saarang and Adeleke, Oluwatobi A and Venters, Bryan J and Drake, Charles G and Baer, Richard and Izar, Benjamin and Guccione, Ernesto and Keogh, Michael-Christopher and Guerois, Raphael and Sun, Lu and Lu, Chao and Califano, Andrea and Ciccia, Alberto},
title = {SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion},
journal = {Cell},
year = {2024},
volume = {187},
number = {4},
pages = {861--881.e32},
doi = {10.1016/j.cell.2024.01.008}
}
EUVIMED